BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 25783158)

  • 1. EGF induces microRNAs that target suppressors of cell migration: miR-15b targets MTSS1 in breast cancer.
    Kedmi M; Ben-Chetrit N; Körner C; Mancini M; Ben-Moshe NB; Lauriola M; Lavi S; Biagioni F; Carvalho S; Cohen-Dvashi H; Schmitt F; Wiemann S; Blandino G; Yarden Y
    Sci Signal; 2015 Mar; 8(368):ra29. PubMed ID: 25783158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of miR-15b decreases cell migration and metastasis in colorectal cancer.
    Li J; Chen Y; Guo X; Zhou L; Jia Z; Tang Y; Lin L; Liu W; Ren C
    Tumour Biol; 2016 Jul; 37(7):8765-73. PubMed ID: 26743779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metastasis suppressor 1 (MTSS1) demonstrates prognostic value and anti-metastatic properties in breast cancer.
    Parr C; Jiang WG
    Eur J Cancer; 2009 Jun; 45(9):1673-83. PubMed ID: 19328678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of MIM by microRNA-182 activates RhoA and promotes breast cancer metastasis.
    Lei R; Tang J; Zhuang X; Deng R; Li G; Yu J; Liang Y; Xiao J; Wang HY; Yang Q; Hu G
    Oncogene; 2014 Mar; 33(10):1287-96. PubMed ID: 23474751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-135a promotes growth and invasion of colorectal cancer via metastasis suppressor 1 in vitro.
    Zhou W; Li X; Liu F; Xiao Z; He M; Shen S; Liu S
    Acta Biochim Biophys Sin (Shanghai); 2012 Oct; 44(10):838-46. PubMed ID: 23017832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-28-5p targets MTSS1 to regulate cell proliferation and apoptosis in esophageal cancer.
    Zhang L; Wang X; Liu X; Lv M; Shen E; Zhu G; Sun Z
    Acta Biochim Biophys Sin (Shanghai); 2020 Aug; 52(8):842-852. PubMed ID: 32645138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-96 promotes the growth of prostate carcinoma cells by suppressing MTSS1.
    Xu L; Zhong J; Guo B; Zhu Q; Liang H; Wen N; Yun W; Zhang L
    Tumour Biol; 2016 Sep; 37(9):12023-12032. PubMed ID: 27164937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of maelstrom promotes bladder urothelial carcinoma cell aggressiveness by epigenetically downregulating MTSS1 through DNMT3B.
    Li XD; Zhang JX; Jiang LJ; Wang FW; Liu LL; Liao YJ; Jin XH; Chen WH; Chen X; Guo SJ; Zhou FJ; Zeng YX; Guan XY; Liu ZW; Xie D
    Oncogene; 2016 Dec; 35(49):6281-6292. PubMed ID: 27181205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metastasis suppressor-1, MTSS1, acts as a putative tumour suppressor in human bladder cancer.
    Du P; Ye L; Ruge F; Yang Y; Jiang WG
    Anticancer Res; 2011 Oct; 31(10):3205-12. PubMed ID: 21965727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of MTSS1 results in increased metastatic potential in pancreatic cancer.
    Zeleniak AE; Huang W; Brinkman MK; Fishel ML; Hill R
    Oncotarget; 2017 Mar; 8(10):16473-16487. PubMed ID: 28146435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The tumour suppressive role of metastasis suppressor-1, MTSS1, in human kidney cancer, a possible connection with the SHH pathway.
    Du P; Ye L; Li H; Yang Y; Jiang WG
    J Exp Ther Oncol; 2012; 10(2):91-9. PubMed ID: 23350348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of miR-193b contributes to enhance urokinase-type plasminogen activator (uPA) expression and tumor progression and invasion in human breast cancer.
    Li XF; Yan PJ; Shao ZM
    Oncogene; 2009 Nov; 28(44):3937-48. PubMed ID: 19701247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA miR-24 enhances tumor invasion and metastasis by targeting PTPN9 and PTPRF to promote EGF signaling.
    Du WW; Fang L; Li M; Yang X; Liang Y; Peng C; Qian W; O'Malley YQ; Askeland RW; Sugg SL; Qian J; Lin J; Jiang Z; Yee AJ; Sefton M; Deng Z; Shan SW; Wang CH; Yang BB
    J Cell Sci; 2013 Mar; 126(Pt 6):1440-53. PubMed ID: 23418360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced Expression of Metastasis Suppressor-1 (MTSS1) Accelerates Progression of Human Bladder Uroepithelium Cell Carcinoma.
    Du P; Wang S; Tang X; An C; Yang Y; Jiang WG
    Anticancer Res; 2017 Aug; 37(8):4499-4505. PubMed ID: 28739745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metastasis suppressor 1 expression in human ovarian cancer: The impact on cellular migration and metastasis.
    Liu R; Martin TA; Jordan NJ; Ruge F; Ye L; Jiang WG
    Int J Oncol; 2015 Oct; 47(4):1429-39. PubMed ID: 26316204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-221/222 targeting of trichorhinophalangeal 1 (TRPS1) promotes epithelial-to-mesenchymal transition in breast cancer.
    Stinson S; Lackner MR; Adai AT; Yu N; Kim HJ; O'Brien C; Spoerke J; Jhunjhunwala S; Boyd Z; Januario T; Newman RJ; Yue P; Bourgon R; Modrusan Z; Stern HM; Warming S; de Sauvage FJ; Amler L; Yeh RF; Dornan D
    Sci Signal; 2011 Aug; 4(186):pt5. PubMed ID: 21868360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MTSS1 and SCAMP1 cooperate to prevent invasion in breast cancer.
    Vadakekolathu J; Al-Juboori SIK; Johnson C; Schneider A; Buczek ME; Di Biase A; Pockley AG; Ball GR; Powe DG; Regad T
    Cell Death Dis; 2018 Mar; 9(3):344. PubMed ID: 29497041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression and clinical significance of miR-23a and metastasis suppressor 1 in colon carcinoma].
    Tang HL; Deng M; Liao QJ; Zeng X; Zhou XT; Su Q
    Zhonghua Bing Li Xue Za Zhi; 2012 Jan; 41(1):28-32. PubMed ID: 22455847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Control of EVI-1 oncogene expression in metastatic breast cancer cells through microRNA miR-22.
    Patel JB; Appaiah HN; Burnett RM; Bhat-Nakshatri P; Wang G; Mehta R; Badve S; Thomson MJ; Hammond S; Steeg P; Liu Y; Nakshatri H
    Oncogene; 2011 Mar; 30(11):1290-301. PubMed ID: 21057539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SCF β-TRCP targets MTSS1 for ubiquitination-mediated destruction to regulate cancer cell proliferation and migration.
    Zhong J; Shaik S; Wan L; Tron AE; Wang Z; Sun L; Inuzuka H; Wei W
    Oncotarget; 2013 Dec; 4(12):2339-53. PubMed ID: 24318128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.